Introduction
In modern neonatal intensive care units (NICUs), perinatalneonatal infections have emerged as predominant causes for mortality and morbidity, especially for very low birth weight (VLBW) infants. Up to 50% of all extremely low birth weight infants 1,2 develop bacterial or candidal sepsis during their hospital stay; these are associated with mortality and up to 30% excess in long-term neurological morbidity.
Although the modes of transmission and etiologic agents for neonatal infections have been delineated, efforts to prevent most of these have been met with limited success. There are no markers for early diagnosis of sepsis, and indicators to distinguish sepsis from systemic inflammatory response syndrome (SIRS) caused by noninfectious etiology are insensitive. Antibiotic therapy, usually begun empirically before the identification of the infecting microbe, can have a role in the increasing prevalence of emerging microbial flora resistant to commonly used antibiotics.
To attempt to address the issues surrounding neonatal infection, the Eunice Kennedy Shriver National Institute of Child Health and Human Development organized a workshop held 7 to 8 August 2008. The objectives of the meeting were to review the current evidence in infectious diseases of the newborn; to identify gaps and challenges in this area; and to develop opportunities for research. As excellent reviews on many of the topics discussed below have been published, this paper provides only a succinct summary of the proceedings related to the objectives of the workshop.
Basic immunology and inflammation
Increased susceptibility to infections in the developing fetus and newborn is due to functional defects of both innate and adoptive immunity. These factors include poor cutaneous and mucosal barriers, fetal 'bias' toward immune tolerance, lack of preexisting antigenic memory, lower concentrations of T and B cells compared with adults and a transition from sterile intrauterine environment to antigen-rich postnatal environment leading to decreased microbial killing. Furthermore, cord blood neutrophils have delayed apoptosis compared with adults, which tend to induce a greater inflammatory response leading to SIRS. Following fetal infection and inflammatory response, the cord blood neutrophils are not effectively removed by the reticulo-endothelial system further contributing to ongoing inflammation and tissue injury. Thus, both pro-and anti-inflammatory cytokines and other mediators are intimately involved in the continued persistence of systemic signs of sepsis even after bacterial killing.
The effects of specific cytokines on cells, tissues and organs may provide insight into the inflammatory response. 3 The effects and consequences of neonatal infection are also modulated by the level of maturity or gestational age of the infant. Novel antiinflammatory agents may provide targeted approaches to reducing inflammation association with infection.
Transcriptional regulation and inflammation: preclinical opportunities Host and microbial virulence factors modulate the magnitude and outcome of neonatal infections. Targeted approaches to antivirulence strategies are necessary for disease prevention and treatment. Some organisms are highly virulent resulting in fulminant sepsis and mortality. Approaches to attenuating virulence, including new models, therapeutics as targets for transcriptional regulators, monoclonal antibodies and small molecule inhibitors, may offer promising approaches to the challenge of neonatal infection. Understanding of the mode of microbial invasion, pathogen ability to evade host immune systems and the biology of microbial toxins may help in developing targeted approaches to preventing and treating perinatalneonatal sepsis.
Definition of sepsis
Several definitions of sepsis have been reported. These include: (a) bacteremia (or isolation of a pathogenic organism from the blood) with signs of sepsis; (b) clinical sepsis where the infant manifests signs of sepsis but the blood or other sterile site culture(s) is sterile; and (c) signs of infection when blood or other sterile body site culture grows what is considered to be a contaminant. However, signs of sepsis are nonspecific. Although SIRS is perhaps the most descriptive way to express sepsis, it is not widely used by clinicians. SIRS generally is caused by bacterial or candidal infection, but noninfectious processes also can add the inflammation component to the general scheme.
Risk factors for sepsis
Many factors have been associated with an increased risk for sepsis in neonates. On the basis of a logistic regression prediction model, Escobar et al. 4, 5 showed that variables best predicting a higher risk for sepsis were: gestational age <32 weeks, high SNAP-II score, birth weight <1250 g, Apgar score of <7, and male gender. Additional risk factors include indwelling arterial and venous catheters and drainage tubes placed in the urinary tract, ventricular, pleural or peritoneal cavities. Maternal risk factors include chorioamnionitis, which can be overt or subclinical.
Another risk factor for neonatal sepsis appears to be maternal exposure to prophylactic antibiotics used when Caesarian sections are performed. Cephalosporins are the most commonly used antibiotics for in this circumstance. Empirical antibiotics also are widely used in NICU patients for suspected infection. Antibiotics have adverse effects and can alter the neonate microbiome. Antibiotics also can select from antimicrobial-resistant pathogens when used inappropriately (routine use or prolonged duration).
Developing intestinal tract, microbiome and neonatal infections
Besides being a digestive organ, the intestine also is a major immune system in the body. Within minutes after birth, the gut begins to be colonized with microbes, which eventually reach the staggering number of 10 13 cells. Such bacterial colonization that influences innate and adoptive immunity is likely to be altered in preterm infants due to the immature gut barrier function, lack of enteral feeds, overall nutritional deprivation and exposure to antimicrobial agents. Studies are needed to understand the intricate role of neonatal intestinal microbiota on developmental immunology, which in turn may help us to modulate the same to enhance immunity, and possibly prevent invasive microbial infections through the intestinal route.
Clinical aspects of sepsis
As the signs of sepsis are nonspecific, it is nearly impossible to distinguish signs of ongoing systemic inflammatory response as opposed to bacteremia or fungemia. The diagnosis of 'suspected sepsis' is extremely common. More accurate assessment tools are desperately needed to discern inflammation from overt infection. Numerous reviews have summarized the limitations of 'standard' investigations for the diagnosing neonatal sepsis. The 'gold standard' test is a single blood culture that is estimated in almost all studies to have a sensitivity of 90% if at least 0.75 ml is collected.
Diagnostic opportunities
Diagnosis of infection ideally is established by tests that are practical, reliable and predictable. Cultures of sterile bodily fluids including blood, cerebrospinal fluid and urine (late-onset only) are obtained from the infant presenting with signs of sepsis. Additional body sites for culture include pleural or peritoneal fluid and visceral or soft tissue abscesses when present. Adjunctive laboratory tests for the presumptive diagnosis of sepsis include white blood cell and differential counts, platelet count, and inflammatory markers, such as C-reactive protein or procalcitonin.
Attention also needs to be given to costs and yields for the cost of diagnostic tests. Proteomic-and DNA-based tests offer promising opportunities. 6 Surrogate markers for infection would greatly assist clinicians in decision making with respect to degree of investigation and treatment strategies selected for patients.
Intravascular catheters
Catheters are a significant contributor to infection. Usually the more unstable and sick infants have the longest exposure to intravascular catheters. Selection of patients for intravenous catheters, catheter insertion technique and protocol, care and maintenance of catheters and criteria for discontinuing catheter use may all be opportunities to refine and limit the use of intravascular lines. If total duration could be limited, then catheter-associated hospital-acquired infection rates likely would decrease. Catheter material and engineering also may be a point of improvement with respect to infection.
Epidemiology and microbial profile
The incidence of proven infection in term infants has been estimated to be 1 to 2 per 1000, or 0.1%, whereas the incidence is B20% in VLBW (<1500 g birth weight) and up to 50% in extremely low birth weight infants (<1000 g). The age at infection also has a bearing on the nature and type of pathogen. Neonatal infections have been classified as early-onset infections (p3 days of age), late-onset (X7 days of age) and very late-onset (X90 days of age). Infections after 48 h of hospitalization in newborn infants have been regarded as hospital-acquired infections. Group B streptococci (GBS) and Gram-negative bacteria (Escherichia coli and Klebsiella species) are the major pathogens causing earlyonset sepsis; by contrast, in decreasing order of frequency, coagulase-negative staphylococci, Candida sp., Staphylococcus aureus, Enterococcus, Klebsiella specdies, E. coli and other bacteria are involved in late-onset healthcare-associated infections. The incidence of early-onset sepsis in the VLBW is about 2%, whereas that of late-onset sepsis is estimated at B20%. 
Emerging infections
Methicillin-resistant Staphylococcus aureus (MRSA) has emerged as an important organism yet its epidemiology in neonates has not been well studied. Community-associated (CA) MRSA is an emerging pathogen and has received much attention. [7] [8] [9] In 2003, six of the eight MRSA blood stream isolates from preterm infants in NICUs as birth had genetic characteristics of the USA 300 clone of CA-MRSA. 9 There is an urgent need for understanding the epidemiology of CA-MRSA in the community at large, as well as in hospitals, including the NICU. The incidence of CA-MRSA in neonates may be rising because of vertical transmission from the mother to the infant causing both early and late-onset infections. Molecular epidemiology should be used to delineate hospitalacquired MRSA and CA-MRSA. Preventive strategies for MRSA and CA-MRSA to control outbreaks may be different. Given the increase in MRSA infections, the clinical pharmacology of agents including vancomycin, daptomycin and perhaps other agents that are active against MRSA are needed in newborn infants.
There is concern for development of drug resistance in bacteria, fungal and viral infections. With increased use of antimicrobials, there is emerging resistance. Influenza and pandemic influenza are emerging as serious and life-threatening diseases in pregnant women and their infants. Immunizations and treatment are recommended for pregnant women as they are at high risk for influenza infection. 10 Ureaplasma and mycoplasma These two etiological agents pose a risk to pregnant women and possibly their infants. 11 Both ureaplasma and mycoplasma can cause endometritis. It is not clear as to whether these two organisms provide promoter or permissive roles in infection.
Epidemiological studies are needed to assess risk and effect on neonatal outcome.
Animal, in vitro and human data point to the proinflammatory cytokine promoting properties of genital mycoplasmas and Ureaplasma urealyticum. This leads to SIRS and has been associated with bronchopulmonary dysplasia and VLBW in some studies.
It is not clear if these organisms are markers of disease outcome. These organisms can act as pathogens and as well as commensal agents. Treatment poses additional questions. There are no pharmacokinetic data on drugs used to treat these organisms or clinical trials of pathogenic versus commensal bacteria that have been conducted in infants.
Prevention of infection
Hand hygiene is an established means of preventing and controlling transmission of bacterial and viral infections in hospitalized patients. This has been well studied, 12, 13 but not uniformly instituted despite strong evidence. Improving adherence to established recommendations may be an opportunity to decrease infection rates in NICUs. Recent adherence rates have been less than 70%. 14, 15 Breast milk has been shown to be protective against a variety of infections in newborn 16 and young infants as well as having a beneficial effect on neurodevelopmental outcome at 2 to 3 years of age. 17, 18 Breast milk contains lactose, nucleotides, oligosaccharides and lactoferrin. Oligosaccharides promote the growth of breastfed gut flora. There are 23 to 130 different oligosaccharides found in human milk. Bifidobacteria are commensal bacteria that utilize oligosaccharides. Lactoferrin is the most prominent whey protein found in human milk. It has antimicrobial, anti-inflammatory and immunomodulatory properties.
Research in epidemiology and surveillance
There is value in targeted registry and surveillance data. There is a need for collaboration with hospital infection control departments on a local level. For population-based studies, one needs to have community inclusion. Infection control scorecards could be a method for surveillance to reduce incidence and severity of infections.
There is a significant cost resulting from sometimes inappropriate antimicrobial use in the areas of alteration of normal flora, adverse events (dose, errors and so on) and toxicity. Methods to promote and implement antimicrobial stewardship in the NICU should be developed.
Infection rates vary among the NICUs, and the precise reason for this remains unknown. Understanding the factors responsible for variations in infection rates could provide opportunities to reduce infection rates that could potentially emerge.
Potential mechanisms to understand differences in infection rate could be defined by looking at the nursery as a system. Infection control practices, the nursery microbiome (that is, pathogens founds in the NICU), skill level and skill practice of the nursery staff, NICU leadership, team functioning, organizational structure, consistency of practice, standardization of practice and physical environment all could be evaluated with respect to center variation. Behavior in the NICU needs to be reviewed periodically. It is hypothesized that different care practices may contribute to different rates of infection within NICU's.
Infection and neurodevelopmental outcome
Neurodevelopmental impairment is much more likely in high-risk infants with infection (culture confirmed or suspected infection) than in infants who do not experience infection. 1 The causative mechanisms are postulated to be inflammatory cytokines and cardiovascular or pulmonary embarrassment resulting in poor perfusion and oxygenation. The inflammatory cytokines may result in an insult at the organ, cellular, subcellular or a combination of all three sites. Protection of neural tissue and neurogenesis may be a pathway to ameliorate damage that occurs with sepsis and infection. Pharmacologic modification may also spare neurodevelopmental outcome. Finally, gestational age likely has a large role in outcomes following infection.
Summary
Infection in the NICU is a significant cause of short-term and longterm morbidity as well as mortality. Strategies to prevent, treat early and avoidance of long-term consequences need to be developed for neonates. Gaps in knowledge and opportunities for research are listed in the Table 1 . In order to advance care for infants, new therapies must progress and be instituted to improve outcome. It is expected that research in the area of neonatal infection will increase over the next decade.
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